MetLife Small Company Equity Fund Institutional Shares (MSVIX)
| Fund Assets | 7.63M |
| Expense Ratio | 0.99% |
| Min. Investment | $100,000 |
| Turnover | 90.00% |
| Dividend (ttm) | 8.59 |
| Dividend Yield | 100.00% |
| Dividend Growth | 737.57% |
| Payout Frequency | Semi-Annual |
| Ex-Dividend Date | Dec 30, 2025 |
| Previous Close | 4.820 |
| YTD Return | -3.98% |
| 1-Year Return | 10.55% |
| 5-Year Return | 35.85% |
| 52-Week Low | 4.670 |
| 52-Week High | 13.860 |
| Beta (5Y) | 0.94 |
| Holdings | 84 |
| Inception Date | Dec 19, 2018 |
About MSVIX
MetLife Small Company Equity Fund Institutional Shares is a mutual fund focused on delivering long-term capital appreciation through investments in U.S. small-cap equities. The fund primarily targets companies with smaller market capitalizations, aiming to harness their growth potential while seeking to maintain less volatility than the broader small company market. Its diversified portfolio typically includes equities across a variety of industries, allowing investors to gain exposure to multiple sectors within the small-cap universe. The fund's management employs a disciplined investment process, which has earned recognition for its soundness and the strength of the team behind it. This fund is benchmarked against the Russell 2000 Index, positioning it as a relevant vehicle for institutions or investors seeking targeted access to small-sized U.S. companies as part of a broader asset allocation strategy. Its institutional share class is designed to meet the needs of larger investors, such as retirement plans or endowments, looking for professional management in the small-cap segment.
Performance
MSVIX had a total return of 10.55% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.52%.
Other Share Classes
These are alternative share classes of the same fund, from the same provider.
| Symbol | Share Class | Expense Ratio |
|---|---|---|
| MSVVX | Investor Shares | 1.24% |
Top 10 Holdings
18.51% of assets| Name | Symbol | Weight |
|---|---|---|
| Cash & Cash Equivalents | n/a | 3.10% |
| Axsome Therapeutics, Inc. | AXSM | 1.97% |
| State Street SPDR S&P Biotech ETF | XBI | 1.82% |
| Halozyme Therapeutics, Inc. | HALO | 1.76% |
| ADMA Biologics, Inc. | ADMA | 1.72% |
| Fortrea Holdings Inc. | FTRE | 1.69% |
| Alphatec Holdings, Inc. | ATEC | 1.66% |
| ACI Worldwide, Inc. | ACIW | 1.61% |
| Bruker Corporation | BRKR | 1.59% |
| ExlService Holdings, Inc. | EXLS | 1.59% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 30, 2025 | $0.0117 | Dec 31, 2025 |
| Dec 18, 2025 | $8.5742 | Dec 19, 2025 |
| Dec 30, 2024 | $0.0293 | Dec 31, 2024 |
| Dec 18, 2024 | $0.9958 | Dec 19, 2024 |
| Dec 28, 2023 | $0.0873 | Dec 29, 2023 |
| Dec 19, 2023 | $0.4663 | Dec 20, 2023 |